...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: No love

The big winner in 2018 was Amarin.  Was Vascepa in the Evaluate list for 2018?  

In most industries, it is the out of left field players that make it big.  I am wiling to bet that it will be Apabetalone for 2019.  It ticks all boxes...probably just like Vascepa did in January 2018.

Share
New Message
Please login to post a reply